In this regard, we include three clinical studies published from 2021 to 2023 based on the inclusion criteria that examined oral curcumin supplementation, primarily in women who were 30 to over 60 years of age (Table 2)
So I was thinking, why on Earth shouldnt I suggest that you could actually do both of those things at the same time with one drug? It was 1995 and Knudsen had recently been tasked with figuring out what to do with the companys GLP-1 program, which had been stagnating amid scientific dead-ends and organizational shake-ups
University of Southern California researchers estimated in a 2023 study that GLP-1 coverage would save Medicare up to $245 billion in 10 years if private insurers also covered the drugs
It means scientists have identified mechanisms worth studying, especially in tissues where inflammation, epithelial barriers, and immune signaling overlap
Currently, Lilly has submitted marketing applications for Orforglipron for weight loss or diabetes treatment in more than 40 countries